Real World Strategies for LDL-Mediated Cardioprotection in High Risk and Statin Intolerant Patients Requiring LDL Reduction - Which Agents? In What Sequence? In Which Patient Subsets? A Roadmap to Clinical Success - James M. McKenney, PharmD

Real World Strategies for LDL-Mediated Cardioprotection in High Risk and Statin Intolerant Patients Requiring LDL Reduction - Which Agents? In What Sequence? In Which Patient Subsets? A Roadmap to Clinical Success - James M. McKenney, PharmD


Published

October 29, 2015

Created by

CMEducation Resources symposium